Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | TERT | O14746 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | PPARD | Q03181 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11130007 | 1.00 | EP300 (0.45) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL11005625 | 1.00 | EP300 (0.45) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL11130016 | 1.00 | EP300 (0.45) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL11005612 | 1.00 | EP300 (0.45) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL11805820 | 1.00 | EP300 (0.45) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL4864006 | 0.92 | LMNA (0.48) | EP300PPARGPPARACYP1A2MAPT | |
| Ether SCHEMBL11035818 | 0.92 | FAAH (0.40) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL20476197 | 0.92 | LMNA (0.48) | EP300PPARGPPARACYP1A2MAPT | |
| SCHEMBL5977367 | 0.91 | TSHR (0.57) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL27854614 | 0.91 | TSHR (0.57) | EP300TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0233629-B1 | COMPOSITIONS FOR TREATEMENT OF VIRAL AND CANCEROUS SKIN LESIONS AND THE LIKE | EXOVIR, INC. (US) | 1991-10-23 | — | — | EP | claimed |
| US-20230372348-A1 | LIPID FORMULATIONS OF TRIAZOLOQUINAZOLINONE COMPOUNDS | GABATHER AB (SE) | 2023-11-23 | — | — | US | disclosed |
| EP-4225275-A1 | LIPID FORMULATIONS OF TRIAZOLOQUINAZOLINONE COMPOUNDS | Gabather AB (SE) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022074457-A1 | LIPID FORMULATIONS OF TRIAZOLOQUINAZOLINONE COMPOUNDS | GABATHER AB (SE) | 2022-04-14 | — | — | WO | disclosed |
| CN-109876149-A | A kind of pharmaceutical carrier and preparation method of apiolin | 山东师范大学 | 2019-06-14 | — | — | CN | disclosed |
| US-20190112348-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK AS (DK) | 2019-04-18 | — | — | US | disclosed |
| US-10259856-B2 | Protease stabilized acylated insulin analogues | NOVO NORDISK A/S (DK) | 2019-04-16 | — | — | US | disclosed |
| US-9688737-B2 | Protease stabilized acylated insulin analogues | NOVO NORDISK A/S (DK) | 2017-06-27 | — | — | US | disclosed |
| EP-2910570-B1 | Protease stabilized, acylated insulin analogues | NOVO NORDISK AS (DK) | 2016-10-12 | — | — | EP | disclosed |
| EP-2910571-B1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK AS (DK) | 2016-10-05 | — | — | EP | disclosed |
| US-20080064760-A1 | Spontaneously Dispersible Pharmaceutical Composition | LI PING | 2008-03-13 | — | — | US | disclosed |
| EP-1807049-A1 | SPONTANEOUSLY DISPERSIBLE PHARMACEUTICAL COMPOSITIONS | Novartis AG (CH) | 2007-07-18 | — | — | EP | disclosed |
| EP-1202719-B1 | ANESTHETIC COMPOSITION FOR INTRAVENOUS INJECTION COMPRISING PROPOFOL | KUHNIL PHARMACEUTICAL CO LTD (KR) | 2006-05-31 | — | — | EP | disclosed |
| WO-2006050123-A1 | SPONTANEOUSLY DISPERSIBLE PHARMACEUTICAL COMPOSITIONS | NOVARTIS AG (CH) | 2006-05-11 | — | — | WO | disclosed |
| US-6743436-B1 | Anesthetic composition for intravenous injection comprising propofol | KUHNIL PHARM. CO., LTD. (KR) | 2004-06-01 | — | — | US | disclosed |
| CN-1149984-C | Anesthetic compositions for intravenous injection containing propofol | ��һ��������ҩ��ʽ���� | 2004-05-19 | — | — | CN | disclosed |
| EP-1202719-A4 | ANESTHETIC COMPOSITION FOR INTRAVENOUS INJECTION COMPRISING PROPOFOL | KUHNIL PHARMACEUTICAL CO LTD (KR) | 2004-03-17 | — | — | EP | disclosed |
| CN-1356896-A | Anesthetic compsn. for intravenous injection comprising propofol | KUHNIL PHARM CO LTD (KR) | 2002-07-03 | — | — | CN | disclosed |
| EP-1202719-A1 | ANESTHETIC COMPOSITION FOR INTRAVENOUS INJECTION COMPRISING PROPOFOL | KUHNIL PHARMACEUTICAL CO., LTD. (KR) | 2002-05-08 | — | — | EP | disclosed |
| WO-2000078301-A1 | ANESTHETIC COMPOSITION FOR INTRAVENOUS INJECTION COMPRISING PROPOFOL | KUHNIL PHARM. CO., LTD. (KR) | 2000-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064760-A1 | Spontaneously Dispersible Pharmaceutical Composition | ABCB11, ABCG2, LIPA | EP300 1478/4885TERT 4136/4885PTPN1 3160/4885 |
| US-20230372348-A1 | LIPID FORMULATIONS OF TRIAZOLOQUINAZOLINONE COMPOUNDS | SOAT1, DGAT1, CPT1A | EP300 1271/4885TERT 3463/4885PTPN1 1262/4885 |
| US-20190112348-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | IAPP, IDE, LIPE | EP300 2091/4885TERT 3566/4885PTPN1 4022/4885 |
| US-10259856-B2 | Protease stabilized acylated insulin analogues | IAPP, IDE, LIPE | EP300 1705/4885TERT 3341/4885PTPN1 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.